SKU:AH 05
Hydryalix Gentle Lidocaine - 1 x 1.25 ml
370,00 lei
370,00 lei
430,00 lei
Super pret
Stoc epuizat
TVA Inclus
Livrarea calculata la pasul urmator
Couldn't load pickup availability
INFORMATII PRODUS
Hydryalix Gentle is indicated for superficial lines, fine and moderate wrinkles, minor skin damage. Can be used on wrinkles, lines and creases around the mouth, great as a skin stimulator.
It is injected into the superficial and middle dermis. Luminera's state-of-the-art technology for creating Hydryalix products, our cross-linked HA product line, offers the advantages of both monophasic crosslinking properties and biphasic gel properties.
Recommended needle > 30G.
Cutina contains: 2 syringes x 1.25 ml
The displayed price is per syringe.
The monophasic gel, which is homogeneously cross-linked, generates a uniform and smooth gel, reduces side effects such as swelling and Tyndall effect, and uses less BDDE for the cross-linking process.
The biphasic gel has two phases, a highly cross-linked phase of HA particles. and a non-cross-linked HA phase in which the particles are suspended. This uncrosslinked phase is necessary to allow injection.
In Hybrid MoBiTM technology, the gel is monophasic, completely homogeneous, smooth and easy to inject. The gel is then cut into different particle sizes, generating a line of differentiated products that are intended for various indications. The nature of the gel particles gives the ability to shape the injected material to the desired shape in the tissue and gives the product firmness. A property not found in standard single-phase products that are available on the market.
It is injected into the superficial and middle dermis. Luminera's state-of-the-art technology for creating Hydryalix products, our cross-linked HA product line, offers the advantages of both monophasic crosslinking properties and biphasic gel properties.
Recommended needle > 30G.
Cutina contains: 2 syringes x 1.25 ml
The displayed price is per syringe.
The monophasic gel, which is homogeneously cross-linked, generates a uniform and smooth gel, reduces side effects such as swelling and Tyndall effect, and uses less BDDE for the cross-linking process.
The biphasic gel has two phases, a highly cross-linked phase of HA particles. and a non-cross-linked HA phase in which the particles are suspended. This uncrosslinked phase is necessary to allow injection.
In Hybrid MoBiTM technology, the gel is monophasic, completely homogeneous, smooth and easy to inject. The gel is then cut into different particle sizes, generating a line of differentiated products that are intended for various indications. The nature of the gel particles gives the ability to shape the injected material to the desired shape in the tissue and gives the product firmness. A property not found in standard single-phase products that are available on the market.
